<DOC>
	<DOCNO>NCT02713334</DOCNO>
	<brief_summary>The objective protocol characterize advance cancer patient ' response learn secondary finding arise tumor genomic profiling , process outcome decision communicate result family .</brief_summary>
	<brief_title>Advanced Cancer Patients Decision Making Family Communication About Secondary Findings From Tumor Genomic Profiling</brief_title>
	<detailed_description>The investigator conduct prospective , observational study advance cancer patient undergoing tumor genomic profiling ( n = 300 ) family member ( anticipated n â‰ˆ 150 ) . Data collection occur embed mixed method design , quantitative ( i.e. , survey ) qualitative ( i.e. , semi-structured interview ) data collect timepoint order obtain complete understand specific process outcome . They recruit already enrol protocol # 12-245 , agree receive secondary finding Consent Part C exist protocol .</detailed_description>
	<criteria>Patients : 18 year age older Has consent MSK IRB protocol # 12245 , Consent A Part C day Has receive secondary finding result MSK IRB protocol # 12245 , Consent Part C per EMR and/or patient report Diagnosed stage IV solid tumor metastatic cancer per EMR and/or clinician judgment Englishfluent ; survey design validated English currently available language . Translation questionnaire language would require reestablish reliability validity measure . Therefore , participant must able communicate English complete survey . Family member : 18 year age old per self report Nominated patient participant family member secondary finding share ( spouses/partners eligible `` family member '' purpose study ) Englishfluent ; survey design validated English currently available language . Translation questionnaire language would require reestablish reliability validity measure . Therefore , participant must able communicate English complete survey . Received genetic test past result pathogenic finding variant unknown significance report EMR . Major psychiatric illness cognitive impairment judgment investigator study staff would preclude study participation Any patient unable comply study procedure determine study investigator study staff .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Decision Making</keyword>
	<keyword>Communication</keyword>
	<keyword>16-080</keyword>
</DOC>